Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

XOMA

XOMA Corp

Dec 08 • 04:00PM ET

15.95

Dollar change -0.09
Percentage change -0.56	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-2.81	Insider Own	0.70%	Shs Outstand	11.45M	Perf Week	3.71%
Market Cap	183.27M	Forward P/E	-	EPS next Y	-0.83	Insider Trans	6.98%	Shs Float	11.41M	Perf Month	4.52%
Income	-32.17M	PEG	-	EPS next Q	-0.36	Inst Own	68.21%	Short Float / Ratio	2.73% / 12.18	Perf Quarter	2.90%
Sales	4.41M	P/S	41.56	EPS this Y	-3.54%	Inst Trans	0.92%	Short Interest	0.31M	Perf Half Y	-7.32%
Book/sh	9.23	P/B	1.73	EPS next Y	59.51%	ROA	-19.76%	Target Price	74.00	Perf Year	-16.18%
Cash/sh	2.93	P/C	5.44	EPS next 5Y	19.00%	ROE	-22.60%	52W Range	13.48 - 23.51	Perf YTD	-13.32%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-30.36%	52W High	-32.16%	Beta	0.46
Dividend %	-	Quick Ratio	3.34	Sales past 5Y	32.47%	Gross Margin	79.32%	52W Low	18.32%	ATR	0.97
Employees	13	Current Ratio	3.34	Sales Q/Q	84.04%	Oper. Margin	-508.21%	RSI (14)	50.35	Volatility	5.55% 6.82%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	-23.72%	Profit Margin	-729.31%	Rel Volume	0.81	Prev Close	16.04
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Nov 07 BMO	Payout	-	Avg Volume	25.59K	Price	15.95
Recom	2.00	SMA20	2.36%	SMA50	-1.22%	SMA200	-8.83%	Volume	20,632	Change	-0.56%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-07-21	Downgrade	Wedbush	Outperform → Neutral	$22
Jun-29-21	Initiated	Aegis Capital	Buy	$60
Jan-19-21	Reiterated	H.C. Wainwright	Buy	$30 → $56
Jan-18-18	Reiterated	H.C. Wainwright	Buy	$38 → $49
Oct-17-17	Resumed	H.C. Wainwright	Buy	$38
Sep-05-17	Upgrade	Wedbush	Neutral → Outperform	$9 → $19
Jun-12-17	Initiated	H.C. Wainwright	Buy	$15
Nov-14-16	Downgrade	Wedbush	Outperform → Neutral	$17 → $14
Mar-11-16	Reiterated	Wedbush	Outperform	$6 → $3
Jul-23-15	Downgrade	Jefferies	Buy → Hold
Jul-22-15	Downgrade	Piper Jaffray	Overweight → Neutral
Jul-22-15	Downgrade	Ladenburg Thalmann	Buy → Neutral
Oct-10-14	Resumed	ROTH Capital	Buy	$9
Apr-29-14	Upgrade	MLV & Co	Hold → Buy	$7
Mar-11-14	Downgrade	MLV & Co	Buy → Hold	$8 → $7
Mar-05-14	Reiterated	Ladenburg Thalmann	Buy	$6.50 → $10
Oct-31-13	Reiterated	MLV & Co	Buy	$7.50 → $8
May-09-13	Reiterated	Ladenburg Thalmann	Buy	$5 → $6
May-14-12	Initiated	Cowen & Co	Outperform
Mar-31-11	Reiterated	MLV Capital	Buy	$12 → $10

Show Previous Ratings

Nov-07-23 07:50AM	Xoma: Q3 Earnings Snapshot (Associated Press Finance) -6.44%
07:30AM	XOMA Reports Third Quarter 2023 Financial Results and Highlights Upcoming Events Expected to Drive Shareholder Value (GlobeNewswire)
Oct-31-23 07:30AM	XOMA Earns $5 Million Milestone Upon FDA Acceptance of Day One's Tovorafenib NDA for Relapsed or Progressive Pediatric Low-Grade Glioma (pLGG) (GlobeNewswire) +5.66%
Sep-25-23 07:30AM	XOMA Declares Quarterly Preferred Stock Dividends (GlobeNewswire) -6.26%
Sep-06-23 07:30AM	XOMA to Present at H.C. Wainwright 25th Annual Global Investment Conference (GlobeNewswire)
10:43PM	Loading…
Aug-31-23 10:43PM	10 Stocks That Are About To Explode (Insider Monkey)
Aug-13-23 10:07AM	Owning 35% shares,institutional owners seem interested in XOMA Corporation (NASDAQ:XOMA), (Simply Wall St.)
Aug-08-23 08:21AM	Xoma: Q2 Earnings Snapshot (Associated Press Finance)
07:30AM	XOMA Reports Second Quarter 2023 Financial Results and Provides Update on its Royalty Monetization Strategy (GlobeNewswire)
Jun-23-23 06:14PM	XOMA Added to the Russell 2000® and Russell 3000® Indexes (GlobeNewswire)
Jun-22-23 07:30AM	XOMA Acquires Royalty and Milestone Economics to Phase 3 First-In-Class Orphan Disease Asset for Niemann-Pick Disease Type C (NPC) and Phase 2 Oncology Asset (GlobeNewswire)
Jun-20-23 07:30AM	XOMA Declares Quarterly Preferred Stock Dividends (GlobeNewswire) +9.30%
May-16-23 09:29AM	Shareholders in XOMA (NASDAQ:XOMA) are in the red if they invested five years ago (Simply Wall St.)
May-09-23 07:53AM	Xoma: Q1 Earnings Snapshot (AP Finance)
07:30AM	XOMA Reports First Quarter 2023 Financial Results and Provides Update on the Acceleration of its Differentiated Royalty Monetization Strategy (GlobeNewswire)
07:30AM	Loading…
Apr-26-23 07:30AM	XOMA to Present at H.C. Wainwright BioConnect Investor Conference (GlobeNewswire) +5.61%
Mar-30-23 07:30AM	XOMA Acquires Cashflow-Generating Asset for its Royalty and Milestone Portfolio (GlobeNewswire)
Mar-21-23 07:30AM	XOMA Declares Quarterly Preferred Stock Dividends (GlobeNewswire)
Mar-10-23 05:36AM	XOMA Full Year 2022 Earnings: Revenues Beat Expectations, EPS In Line (Simply Wall St.)
Mar-09-23 07:50AM	Xoma: Q4 Earnings Snapshot (AP Finance) +5.76%
07:30AM	XOMA Reports Full-Year 2022 Financial Results and Provides Update to the Acceleration of its Differentiated Royalty Monetization Strategy (GlobeNewswire)
Mar-06-23 08:28AM	XOMA Corporation's (NASDAQ:XOMA) largest shareholders are individual investors with 37% ownership, hedge funds own 32% (Simply Wall St.)
Feb-28-23 07:30AM	XOMA to Present at 43rd Annual Cowen Health Care Conference (GlobeNewswire)
Jan-06-23 07:00PM	XOMA Announces New Employment Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jan-04-23 07:30AM	New Executive Leadership Team Appointed to Accelerate XOMAs Differentiated Royalty Monetization Strategy (GlobeNewswire)
Dec-22-22 07:30AM	XOMA Declares Quarterly Preferred Stock Dividends (GlobeNewswire)
Dec-07-22 07:44AM	XOMA (NASDAQ:XOMA) shareholders have endured a 39% loss from investing in the stock five years ago (Simply Wall St.)
Nov-22-22 07:01AM	XOMA Acquires Royalty and Milestone License to Ebopiprant, a Preterm Labor Asset, Being Developed by Organon (GlobeNewswire) +15.91%
Nov-06-22 09:24AM	XOMA Corporation's (NASDAQ:XOMA) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong? (Simply Wall St.)
Nov-03-22 09:05AM	Xoma (XOMA) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
07:30AM	Loading…
07:30AM	XOMA Reports Third Quarter 2022 Financial Results and Highlights Recent Operational Events (GlobeNewswire)
Sep-27-22 08:30AM	Hedge funds own 31% of XOMA Corporation (NASDAQ:XOMA) shares but individual investors control 40% of the company (Simply Wall St.)
Sep-21-22 07:30AM	XOMA Declares Quarterly Preferred Stock Dividends (GlobeNewswire)
Sep-07-22 07:30AM	XOMA to Present at H.C. Wainwright 24th Annual Global Investment Conference (GlobeNewswire)
Sep-01-22 06:20AM	Is There An Opportunity With XOMA Corporation's (NASDAQ:XOMA) 49% Undervaluation? (Simply Wall St.) -7.34%
Aug-11-22 06:22AM	Time To Worry? Analysts Are Downgrading Their XOMA Corporation (NASDAQ:XOMA) Outlook (Simply Wall St.)
Aug-04-22 10:45AM	Xoma (XOMA) Reports Q2 Loss, Misses Revenue Estimates (Zacks) -6.64%
07:30AM	XOMA Reports Second Quarter 2022 Financial Results and Highlights Recent Operational Events (GlobeNewswire)
Jun-30-22 07:33AM	Investing in XOMA (NASDAQ:XOMA) five years ago would have delivered you a 196% gain (Simply Wall St.) +8.95%
Jun-20-22 07:30AM	XOMA Declares Quarterly Preferred Stock Dividends (GlobeNewswire)
Jun-02-22 01:00AM	Kuros Biosciences: Completion of the Acquisition of Checkmate Pharmaceuticals by Regeneron Pharmaceuticals Triggers a $5 Million Milestone Payment (GlobeNewswire)
May-30-22 07:06AM	Is Weakness In XOMA Corporation (NASDAQ:XOMA) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects? (Simply Wall St.)
May-17-22 04:05PM	XOMA to Present at H.C. Wainwright Global Investment Conference (GlobeNewswire)
May-07-22 08:27AM	This Just In: Analysts Are Boosting Their XOMA Corporation (NASDAQ:XOMA) Outlook for This Year (Simply Wall St.)
May-05-22 08:55AM	Xoma (XOMA) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
07:30AM	XOMA Reports First Quarter 2022 Financial Results and Highlights Recent Operational Events (GlobeNewswire)
May-03-22 08:15AM	Kymera Therapeutics, Inc. (KYMR) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
Apr-20-22 08:24AM	What Is The Ownership Structure Like For XOMA Corporation (NASDAQ:XOMA)? (Simply Wall St.)
Mar-21-22 07:30AM	XOMA Declares Quarterly Preferred Stock Dividends (GlobeNewswire)
Mar-15-22 06:21AM	XOMA Corporation's (NASDAQ:XOMA) 32% Share Price Surge Not Quite Adding Up (Simply Wall St.)
Mar-10-22 09:43AM	XOMA Corporation (NASDAQ:XOMA) Shares Could Be 20% Below Their Intrinsic Value Estimate (Simply Wall St.)
07:30AM	XOMA to Present at Oppenheimers 32nd Annual Healthcare Conference (GlobeNewswire)
Mar-08-22 07:30AM	XOMA Reports Full Year 2021 Financial Results and Highlights Recent Operational Events (GlobeNewswire) +11.47%
Mar-01-22 07:30AM	XOMA to Present at the 42nd Annual Cowen Health Care Conference (GlobeNewswire)
Feb-17-22 07:30AM	XOMA to Present at Aegis Capital Corp Investor Conference (GlobeNewswire)
Jan-21-22 10:21AM	XOMA's (NASDAQ:XOMA) investors will be pleased with their massive 368% return over the last five years (Simply Wall St.)
Dec-23-21 07:30AM	XOMA Declares Quarterly Preferred Stock Dividends (GlobeNewswire)
Dec-21-21 07:30AM	XOMA to Present at Upcoming Investor Conferences (GlobeNewswire) +7.94%
Dec-16-21 07:30AM	XOMA Announces Evolution of Company Leadership and Succession Planning (GlobeNewswire)
Nov-22-21 11:46AM	Should Weakness in XOMA Corporation's (NASDAQ:XOMA) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials? (Simply Wall St.)
Nov-15-21 06:01AM	10 Best Biotech Stocks to Buy According to Mark Lamperts Biotechnology Value Fund (Insider Monkey)
Nov-04-21 10:15AM	Xoma (XOMA) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
07:40AM	XOMA Earns $35 Million Milestone Payment as Anti-TGF Antibody Enters Phase 3 Clinical Study in Metastatic Pancreatic Cancer (GlobeNewswire)
07:30AM	XOMA Reports Third Quarter 2021 Financial Results and Highlights Recent Operational Events (GlobeNewswire)
Oct-28-21 03:06PM	Will Xoma (XOMA) Report Negative Q3 Earnings? What You Should Know (Zacks)
Oct-27-21 04:50AM	10 Pharma Stocks to Buy According to Mark Lamperts Biotechnology Value Fund (Insider Monkey)
Oct-14-21 06:57AM	10 Pharmaceutical Stocks to Buy According to Timothy Lynchs Stonepine Capital (Insider Monkey)
Oct-08-21 03:35AM	Strength Seen in Xoma (XOMA): Can Its 11.2% Jump Turn into More Strength? (Zacks) +8.96%
Sep-22-21 07:30AM	XOMA to Present at the 2021 Cantor Fitzgerald Virtual Global Healthcare Conference (GlobeNewswire)
Sep-21-21 12:33PM	Here's What XOMA Corporation's (NASDAQ:XOMA) Shareholder Ownership Structure Looks Like (Simply Wall St.)
Sep-20-21 07:30AM	XOMA Declares Quarterly Preferred Stock Dividends (GlobeNewswire) -6.94%
Sep-13-21 07:30AM	XOMA to Present at H.C. Wainwright 23rd Annual Global Investment Conference (GlobeNewswire)
Sep-07-21 01:49PM	Why Did Wedbush Downgrade Xoma? (Benzinga) -12.53%
Aug-10-21 04:35PM	XOMA Announces Heather L. Franklin Joins its Board of Directors (GlobeNewswire)
Aug-05-21 08:45AM	Xoma (XOMA) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
07:30AM	XOMA Reports Second Quarter 2021 Financial Results and Highlights Recent Operational Events (GlobeNewswire)
Jul-29-21 03:05PM	Earnings Preview: Xoma (XOMA) Q2 Earnings Expected to Decline (Zacks) -5.18%
Jul-28-21 07:30AM	U.S. Food and Drug Administration has Granted Orphan Drug Designation to XOMAs Licensed anti-TGF Asset NIS793 (GlobeNewswire)
Jul-15-21 06:38AM	XOMA Buys Royalty, Milestone Interest In Checkmate's Vidutolimod From Kuros Biosciences (Benzinga)
04:17AM	Kuros to receive $7 million up front and potentially $166.5 million in future revenues under a royalty purchase agreement with XOMA related to Kuross license agreement with Checkmate Pharmaceuticals (GlobeNewswire)
04:00AM	XOMA Acquires Royalty and Milestone Interest in Checkmates Vidutolimod (CMP-001) from Kuros Biosciences (GlobeNewswire)
Jun-23-21 03:16PM	Is XOMA Corp (XOMA) A Good Stock To Buy? (Insider Monkey)
Jun-21-21 07:30AM	XOMA Declares Quarterly Preferred Stock Dividends (GlobeNewswire)
Jun-08-21 10:38AM	XOMA Corporation (NASDAQ:XOMA) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap? (Simply Wall St.)
May-21-21 08:00AM	XOMA Licensees to Present Significant Clinical Data at 2021 ASCO Annual Meeting (GlobeNewswire)
May-06-21 09:15AM	Xoma (XOMA) Reports Q1 Loss, Misses Revenue Estimates (Zacks) -8.73%
07:30AM	XOMA Reports First Quarter 2021 Financial Results and Highlights Recent Operational Events (GlobeNewswire)
May-03-21 07:30AM	XOMA Earns Milestone for First Patient Dosed in Phase 3 Development Program (GlobeNewswire)
Apr-15-21 09:05AM	XOMAs Royalty Portfolio Grows with Addition of Three Royalty Assets (GlobeNewswire)
Apr-12-21 07:30AM	XOMA Announces Closing of Depositary Shares Offering and Exercise of Underwriters Option (GlobeNewswire)
Apr-06-21 07:02PM	XOMA Prices $35 Million Offering of Depositary Shares (GlobeNewswire)
Apr-05-21 04:05PM	XOMA Announces Offering of Depositary Shares and Series B Cumulative Perpetual Preferred Stock (GlobeNewswire)
Mar-23-21 08:00AM	Viracta and XOMA Announce Multi-License Milestone and Royalty Monetization Transaction (PR Newswire)
Mar-22-21 07:30AM	XOMA Announces Approval of First Preferred Stock Dividend (GlobeNewswire)
Mar-10-21 08:45AM	Xoma (XOMA) Beats Q4 Earnings and Revenue Estimates (Zacks)
07:30AM	XOMA Reports Fourth Quarter and Full-Year 2020 Financial Results and Operating Highlights (GlobeNewswire)
Mar-03-21 05:16AM	What Type Of Shareholders Own The Most Number of XOMA Corporation (NASDAQ:XOMA) Shares? (Simply Wall St.)
Mar-02-21 12:30PM	Xoma (XOMA) to Report Q4 Results: Wall Street Expects Earnings Growth (Zacks)
Feb-23-21 04:05PM	XOMA to Present at Upcoming Investor Conferences (GlobeNewswire)
Jan-04-21 04:05PM	XOMA to Present at H.C. Wainwright Virtual BioConnect 2021 and Biotech Showcase Digital Conferences (GlobeNewswire) -9.77%

XOMA Corp. engages in the discovery and development of therapeutics derived from platform of antibody technologies. Its products includes X358, X213, X129, and gevokizumab. The company was founded by Patrick J. Scannon in 1981 and is headquartered in Emeryville, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Sitko Bradley	Chief Investment Officer	Oct 03	Buy	13.89	250	3,472	5,600	Oct 04 04:30 PM
Sitko Bradley	Chief Investment Officer	Oct 02	Buy	14.25	1,500	21,375	5,350	Oct 04 04:30 PM
Hughes Owen	Exec Chairman and Interim CEO	Oct 02	Buy	13.83	1,000	13,830	3,500	Oct 04 04:30 PM
Hughes Owen	Exec Chairman and Interim CEO	Sep 26	Buy	14.43	2,499	36,061	2,500	Sep 27 04:30 PM
Hughes Owen	Exec Chairman and Interim CEO	Sep 25	Buy	14.65	1	15	1	Sep 27 04:30 PM
Sitko Bradley	Chief Investment Officer	May 31	Buy	17.13	1,500	25,700	3,500	Jun 02 04:30 PM
Hughes Owen	Interim CEO	May 24	Buy	23.79	1,032	24,551	2,000	May 25 04:30 PM
Hughes Owen	Interim CEO	May 23	Buy	23.46	968	22,706	968	May 25 04:30 PM
Sitko Bradley	Chief Investment Officer	May 23	Buy	19.00	850	16,150	3,850	May 25 04:30 PM
Sitko Bradley	Chief Investment Officer	May 19	Buy	19.50	1,000	19,500	3,000	May 22 04:30 PM
Sitko Bradley	Chief Investment Officer	May 16	Buy	23.20	500	11,602	2,000	May 17 05:20 PM
Sitko Bradley	Chief Investment Officer	May 15	Buy	23.40	1,500	35,100	1,500	May 16 04:13 PM
Sitko Bradley	Chief Investment Officer	May 12	Buy	18.99	2,000	37,985	2,000	May 16 04:13 PM
BVF PARTNERS L P/IL	Director	Jan 06	Buy	21.98	3,249	71,419	1,789,844	Jan 09 05:44 PM
BVF PARTNERS L P/IL	Director	Jan 05	Buy	18.39	19,000	349,319	1,788,168	Jan 09 05:44 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

XOMA

XOMA Corp

Upgrade your FINVIZ experience